Fundraising FoxAccess Biotechnology — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Thumbnail for Surrozensurrozen.cominJun 2020
Surrozen develops multifunctional biologic therapies that selectively activate Wnt signaling to address ophthalmic diseases with unmet medical needs.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Anna Berkenblit(Director)Harold Varmus(Director)
BoardDavid Goeddel(Director)inCraig Parker(Executive Officer, Director)Tim Kutzkey(Director)in
Co-investors5AM VenturesThe Column GroupHorizons Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.